Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1538-2443
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab ; volume:28 ; number:2 ; day:23 ; month:3 ; year:2022 ; pages:335-338 ; date:4.2022
Journal of neurovirology ; 28, Heft 2 (23.3.2022), 335-338, 4.2022
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13365-022-01059-2
- URN
-
urn:nbn:de:101:1-2022080623012831446267
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.04.2032, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Boesl, Fabian
- Allers, Kristina
- Herm, Juliane
- Scheider, Thomas
- Franke, Christiana
- SpringerLink (Online service)
Ähnliche Objekte (12)
Progressive multifocal leukoencephalopathy in AIDS
Intravenous immunoglobulins in neurological diseases
Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy in the absence of immunosuppression
Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy
Evolution of progressive multifocal leukoencephalopathy in HIV-infected patients
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Smoldering myeloma presenting as progressive multifocal leukoencephalopathy: a case report
Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy in AIDS
Intravenous immunoglobulins in neurological diseases
Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy in the absence of immunosuppression
Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy
Evolution of progressive multifocal leukoencephalopathy in HIV-infected patients
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Smoldering myeloma presenting as progressive multifocal leukoencephalopathy: a case report
Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy in AIDS
Intravenous immunoglobulins in neurological diseases
Innovative therapeutic concepts of progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy in the absence of immunosuppression
Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy
Evolution of progressive multifocal leukoencephalopathy in HIV-infected patients
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
Smoldering myeloma presenting as progressive multifocal leukoencephalopathy: a case report